Journal
Information Content Entity
Continuant
Continuant
Entity
Entity
Periodical
Generically Dependent Continuant
Collection
2025-06-26T13:06:35
RDF description of JTO Clin Res Rep - http://repository.healthpartners.com/individual/journal-JTO-Clin-Res-Rep
public
journal-JTO-Clin-Res-Rep
JTO Clin Res Rep
Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299
Alliance Foundation Trial 09: a randomized, multicenter, phase 2 trial evaluating two sequences of pembrolizumab and standard platinum-based chemotherapy in patients with metastatic NSCLC